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Ubiquitin (Ub) is a small protein that post-translation-
ally modifies a variety of substrates in eukaryotic
cells to modulate substrate function. The ability of
Ub to interact with numerous protein domainsmakes
Ub an attractive scaffold for engineering ubiquitin
variants (UbVs) with high target specificity. Previ-
ously, we identified a UbV that formed a non-cova-
lent stable dimer via a b-strand exchange, and in
the current work we identified and characterized
the minimal substitutions in the primary sequence
of Ub required to form a higher ordered complex. Us-
ing solution angle scattering and X-ray crystallog-
raphy, we show that a single substitution of residue
Gly10 to either Ala or Val is sufficient to convert Ub
from a monomer to a dimer. We also investigate
contributions to dimer formation by the residues in
the surrounding sequence. These results can be
used to develop next-generation phage-display
libraries of UbVs to engineer new interfaces for pro-
tein recognition.
INTRODUCTION
Ubiquitin (Ub) is a small 76-amino-acid protein that functions as
a post-translational modifier on a wide range of substrate pro-
teins in the eukaryotic cell (Hershko and Ciechanover, 1998).
The process of ubiquitination is initiated by E1, which uses
Mg2+-ATP to activate Ub and conjugate it to an E2 Ub-conju-
gating enzyme via a thioester bond between the C-terminal di-
glycine on Ub and a catalytic cysteine on the E2. Ub from this
E2Ub complex ( denotes the thioester bond) is then trans-
ferred to a substrate in a reaction mediated by an E3 ligase,
thereby forming an isopeptide bond between the C-terminal
glycine of Ub and a free amine group from a substrate lysine or
N-terminal methionine (Komander and Rape, 2012; Pickart andStructure 27, 1–8, Sep
This is an open access article undEddins, 2004). E3 ligases are divided into three families depend-
ing on the Ub transfer mechanism (Buetow and Huang, 2016)—
HECT, RING, and RING between RING—and of these three,
RING E3s are the most abundant (Deshaies and Joazeiro,
2009). Ub also associates with many proteins via non-covalent
interactions, and a wide range of proteins have Ub-associated
domains and Ub-binding domains to facilitate this type of inter-
action (Dikic et al., 2009).
Because Ub uses a common surface to interact with a wide
variety of proteins with relatively low affinity, it is an attractive
scaffold for engineering variants with greater specificity for
select targets (Ernst et al., 2013; Leung et al., 2017). Previ-
ously, we generated a ubiquitin variant (UbV) library (Ernst
et al., 2013) and used phage display to select UbVs that target
and modulate the activities of multiple classes of proteins
including deubiquitinases (DUBs), HECT E3 and RING E3 li-
gases, and Ub-interacting motifs (Brown et al., 2016; Gabriel-
sen et al., 2017; Gorelik et al., 2016; Manczyk et al., 2017;
Zhang et al., 2016, 2017a, 2017b). Using this method, we un-
expectedly identified a dimeric UbV that is selective for the
RING domain of XIAP (hereafter referred to as XR) (Gabrielsen
et al., 2017). In crystal structures of this UbV alone and bound
to XR, b1 and b10 from the two UbV chains are swapped, form-
ing an elongated strand that fulfills all hydrogen-bonding
criteria required to complete the b-sheet criteria (Figure 1A)
that occur between b1 and b2 in wild-type Ub. When purified
by size-exclusion chromatography, this XR-selective UbV,
herein termed UbV.XR, was present in two populations: one
corresponding to the molecular weight of a dimer and the
other corresponding to that of a monomer. Over time, there
was a shift in the population from monomeric to dimeric
UbV.XR, and the dimer population was eliminated by reverting
Ala10 in UbV.XR to Gly, the corresponding residue in wild-
type Ub.
In addition to position 10, Ub and UbV.XR differ at a num-
ber of other positions in b1 and the loop between b1 and b2,
which could influence dimerization. In this work, we have
determined the minimum substitutions required to convert
wild-type Ub from a stable monomer to a dimer by intro-
ducing point mutations in b1 and the loop between b1 andtember 3, 2019 ª 2019 The Author(s). Published by Elsevier Ltd. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Substitution of Gly10 to Ala or Val in Ub74 Promotes Dimerization
(A) Crystal structure of XIAP RING (gray) and dimeric UbV.XR (green and blue) (PDB: 5O6T).
(B) Sequence alignments of ubiquitin (Ub), UbV.XR, and UbV.pCBL (Gabrielsen et al., 2017) with NEDD8-Ubl and SUMO2-Ubl created with ALINE (Bond and
Sch€uttelkopf, 2009). Numbering is based on ubiquitin, and identical residues are highlighted in black. Residue 10 is highlighted in red.
(C) Normalized analytical size-exclusion chromatograms of Ub74 and variants with substitutions of Gly to Ala or Val in position 10. The profiles of Ub74 G10A and
G10V have peaks that elute at volumes consistent with a dimer. See also Figure S1A.
(D) Normalized analytical size-exclusion chromatograms of Ub74 G10L immediately following purification and after incubation at 4C for 14 days. There is no shift
from monomer to dimer. See also Figures S1B and S1C.
(E) Stability of Ub74Gly10 variants asmeasured in a thermofluorescence assay. Themonomeric fractions of Ub74G10A andG10V have lowermelting points than
Ub74, Ub74 G10F, and Ub74 G10M. Assays were performed in triplicate, and melting points and standard error were calculated using a Boltzmann sigmoid fit in
GraphPad Prism. The curves shown are from one set of assays.
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Ub protein characteristics, but will allow us to design dimeric
libraries of UbVs to expand our target space for developing
selective modulators of cellular activity for Ub-binding
proteins.
RESULTS
Substitution of Gly10 Is Sufficient to Promote
Oligomerization
Of the many structures of UbVs in complex with their binding
partners determined to date, only UbV.XR has been reported
to exist as a dimer. Sequence and structural comparisons of2 Structure 27, 1–8, September 3, 2019Ub with the UbVs that have been crystallized suggest that sub-
stitution of Gly10might be sufficient to promote Ub dimerization
(Figure 1B). In UbV.XR, Ala10was shown to be crucial for dimer-
ization. When this residue was reverted to Gly, the variant re-
mained monomeric even when left at 4C for a week whereas
the UbV.XR Ala10 monomer population shifted toward dimer
in the same time frame (Gabrielsen et al., 2017). However, in
UbV.XR, there are a number of additional amino acid substitu-
tions in this region that have not been excluded from having a
role in UbV.XR dimerization. To determine whether a single
substitution of residue Gly10 in Ub promotes oligomerization,
we introduced Gly10 substitutions of increasing size into a
construct of Ub lacking the C-terminal diglycine motif (Ub74).
Figure 2. Ub74 G10V and Ub74 Adopt
Different Conformations
(A) Scaled experimental intensity plots of Ub74
(blue) and Ub74G10V (red) show a clear difference
in the conformations of the two samples in solu-
tion. The colors representing each sample are
consistent throughout the figure.
(B) Guinier plot of Ub74 and Ub74 G10V with re-
siduals shown below. Rg values of 14.4 A˚ and
23.9 A˚ were derived from these data for Ub74 and
Ub74 G10V, respectively.
(C) Kratky plots of Ub74 and Ub74 G10V, high-
lighting the fundamental differences between the
two proteins in solution.
(D) Relative pair distribution function (P(r)) of Ub74
with a Dmax of 44 A˚ and Ub74 G10V with a Dmax of
76 A˚.
(E)Ab initio reconstruction of Ub74 superposed on
the crystal structure of Ub from PDB: 1UBQ.
(F) Ab initio reconstruction of Ub74 G10V super-
posed on the crystal structure from this study.
(G) Crystal structure of Ub74 G10V dimer, showing
how b1 has exchanged position with b10 from the
partnering subunit. Note that the overall Ub fold is
maintained for both chains.
(H) Close-up of G10V and the b1b2 loop with
Polder map contoured at 2s.
(I) Solution scattering of Ub74 G10V, fitted with the
theoretical scattering curve of the crystal structure
of Ub74 G10V.
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substituting Gly10 in Ub74 with Ala, Val, Leu, Met, Phe, or Arg
promoted dimer formation (Figures 1C and S1A) and found
that the Ala and Val substitutions existed in two populations
that eluted at volumes consistent with the molecular weights
of a Ubmonomer and dimer. When left at 4C for a week, a frac-
tion of the monomer at10 mg/mL slowly converted to a mix of
monomeric and dimeric Ub, whereas when left for a week, afraction of the dimer at 10 mg/mL did
not revert to monomer (Figures S1B
and S1C). When Gly10 was substituted
with residues with larger side chains, lit-
tle evidence of dimer formation was
observed, even after a 2-week incuba-
tion at 4C as shown for Ub74 G10L (Fig-
ure 1D). We also measured melting tem-
peratures of Ub74 and the position-10
variants using dynamic fluorescence
scanning to assess stability. While
Ub74 and Ub74 G10M had melting tem-
peratures of 85.5C ±0.2C and 86.3C ±
0.2C, respectively, the monomeric frac-
tions of variants with Ala and Val substi-
tutions had melting temperatures of
79.9C ± 0.7C and 81.9C ± 0.2C,
respectively, showing that these two var-
iants are less stable (Figure 1E). How-
ever, the Ub74 G10F substituted sample
had a melting temperature of 84.3C ±
0.3C yet remained monomeric. Thesedata show that factors other than mutation-induced instability
may contribute to non-covalent dimer formation by Ub.
Ub74 and Ub74 G10V Have Distinct Shapes in Solution
To confirm observations from our gel-filtration analyses, we
analyzed Ub74 and the dimer fraction of Ub74 G10V using
small-angle X-ray scattering (SAXS). The intensity and Kratky
plots are dramatically different for the two samples (Figures 2AStructure 27, 1–8, September 3, 2019 3
Table 1. Data Collection and Refinement Statistics
Ub74 G10V
Data Collection
PDB ID 6QK9
Space group P212121
Cell dimensions
a, b, c (A˚) 83.93, 87.26, 109.84
a, b, g () 90, 90, 90
Resolution (A˚) 29.16–2.23 (2.29–2.23)a
Rmerge (%) 9.3 (76.4)
Rpim (%) 5.8 (48.5)
Completeness (%) 99.4 (93.1)
Multiplicity 6.6 (6.1)
I/sI 13.2 (2.0)
CC1/2 0.98 (0.85)
Wilson B (A˚2) 34.7
Refinement
Rwork (%) 23.90
Rfree (%) 28.1
No. of atoms
Protein 13,886
Water 204
RMSD bond 0.010
RMSD angle 1.321
B factors
Main chain 40.4
Side chain 49.9
Ramachandran favorable (%) 99.65
Additional allowed (%) 0.35
aValues in parentheses are for highest-resolution shell.
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drastically alters the size and shape of Ub. The radius of gyration
(Rg) andmaximumdistance (Dmax) were 14.4 A˚ and 44 A˚ for Ub74
and 23.9 A˚ and 76 A˚ for Ub74 G10V (Figures 2C and 2D), respec-
tively; these clearly show that Ub74G10V forms a larger complex
in solution than Ub74. The Dmax and Rg of Ub74 G10V appear to
be concentration independent, suggesting that the dimeric state
does not change with protein concentration within our tested
range (6.25–50 mg/mL). Additionally, when we calculated ab ini-
tio models of Ub74 G10V and Ub74 based on the experimental
data collected, the calculated bead models were distinctly
different (Figures 2E and 2F), and when high-resolution struc-
tures of Ub are superposed on the envelopes, the Ub74 G10V
envelope accommodates twomolecules of Ub and the Ub74 en-
velope one. Together these data show that Ub74 and Ub74
G10V adopt different conformations in solution consistent in
size with a monomer and dimer, respectively.
Molecular Structure of Ub74 G10V
To investigate whether Ub74 G10V resembled the UbV.XR
dimer, we determined the structure to a resolution of 2.23 A˚
from crystals grown from the dimeric gel-filtration fractions.
There are 12 chains in the asymmetric unit forming six dimers,4 Structure 27, 1–8, September 3, 2019in which the b1 strands from both subunits of the dimer are
swapped and complete the b sheet in the partnering subunit (Fig-
ure 2G and Table 1) as observed in UbV.XR.
Polder maps (Liebschner et al., 2017) (Figure 2H) confirm that
the electron density for the b1b2 loop clearly extends between
two adjacent chains such that b1 interacts with b20 on a neigh-
boring chain to form a b sheet. Additionally, there are no signifi-
cant differences between the B factors of the atoms involved in
the b1 exchange and the remainder of the atoms in each mole-
cule of the dimer. The quality of chains D and H (part of dimers
CD and GH, respectively) is poorer than that of the others, re-
flected by the higher average B factors of these chains (72 and
62 A˚, respectively) when compared with the overall average B
factor of all chains (51 A˚). The complementary chains in each
dimer pair have a complete elongated b1 strand.
Comparison of the crystal structure and solution studies of
Ub74 G10V suggests that the dimer from the crystal structure
is also present in solution. A theoretical scattering curve calcu-
lated from the crystal structure fits well to the solution data
with a c2 value of 3.8 compared with the crystal structure of
Ub74, which fits with a c2 of 20.8 (Figure 2I), and the crystal
structure of the Ub74 G10V dimer was easily superposed with
the envelope calculated from the solution scattering data (Fig-
ure 2F). In addition, the calculated Rg of the Ub74 G10V crystal
structure is 21.5 A˚ (CRYSOL), fitting closely with the experimen-
tally obtainedRg. In comparison, the calculatedRg of monomeric
Ub from a crystal structure of Ub (1UBQ) and experimentally
determined Rg from Ub74 are 13.6 and 14.0 A˚, respectively.
These data suggest that the Ub74 G10V dimer is not merely a
crystallographic artifact.
The dimer interface comprises around 1,800 A˚2 of an overall
accessible surface area of6,000 A˚2 for each subunit. There ap-
pears to be a certain degree of freedom around the dimerization
arm, producing two distinct populations of dimers in the asym-
metric unit. The first population consists of the chain pairs AB
and IJ, which superpose with a root-mean-square deviation
(RMSD) of 1.55 A˚ for 2,139 atoms, and the second population
consists of chain pairs EF, KL, and GH, which all superpose
with an RMSD of less than 0.8 A˚ for 2,000 atoms. When chain
pairs from the two populations are superposed, the RMSD in-
creases to2.4 A˚. Chain pair CD sits in a conformation between
the two populations, superposing to AB and EF with RMSDs of
2.3 and 1.48 A˚, respectively, highlighting the flexibility of the
dimerization arm.
The main source of divergence between these two popula-
tions arises due to differences in rotation between the two Ub
bodies in the dimer subunits. To compare the compactness of
the dimer populations, we measured the distance between
Leu69 in both subunits, which sits near the dimer interface,
and found that both populations of dimer subunits are separated
by a distance of about 20 A˚ for AB, 21 A˚ for CD, and 22 A˚ for EF
(Figure 3A). Furthermore, we measured the angle formed be-
tween Asp39, Val10, and Asp390 to describe the rotation be-
tween the two molecules (Figure S1D). The populations differ
quite dramatically, with angles of 144 for AB, 159 for CD, and
163 for EF.While these differences are obvious in the crystal lat-
tice, theoretical scattering profiles calculated for each dimer
configuration show no detectable differences between the two
forms in solution. When compared with the published UbV.XR
Figure 3. Dimerization Criteria
(A) Superposed Ca-ribbon traces of chain AB (magenta) and chain EF (cyan) dimers from the two populations in the asymmetric unit of the crystal structure of
Ub74 G10V, in wall-eye stereo. Leu69 from each subunit is shown as sticks and the dotted line shows the distance measured. See also Figure S1D.
(B) Superposed Ca-ribbon traces of UbV.XR alone (green, PDB: 5O6S) and Ub74 G10V (cyan). Leu69 from each subunit is shown as sticks.
(legend continued on next page)
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UbV dimer.
The b1b2 Loop Is Important for the Stability of Ub
Because substitution of G10 to Val changes the oligomeric state
of Ub from a monomer to a dimer, we set out to determine
whether the monomer could be recovered if a glycine was intro-
duced elsewhere in the b1b2 loop (Figure 1B). Initially, residues
Leu8 and Thr12 were substituted with glycine in Ub74 G10V,
and analyzed by analytical size-exclusion chromatography as
described above. Ub74 L8G G10V was monomeric, whereas
Ub74G10V T12Gwas dimeric (Figure 3C). To expand on the bor-
ders of where the glycine substitution can occur and still recover
the monomeric state, we made a range of individual substitu-
tions with glycine in Ub74 G10V, namely Phe4, Val5, Lys6,
Thr7, Lys11, Ile13, Thr14, or Leu15. Ub74 G10V with V5G or
T7G substitutions did not express soluble protein. When Phe4
or Lys6 was substituted with glycine in Ub74 G10V, the protein
remained a dimer (Figure S1E). While a Lys11 substitution with
Gly was monomeric, when Ile13, Thr14, or Leu15 was
substituted with Gly in Ub74 G10V, the protein was predomi-
nantly a dimer (Figure S1F). Based on these gel-filtration profiles,
our data suggest that a Gly substitution within the b1b2 loop of
Ub74 G10V is sufficient to maintain the monomeric state of
Ub; however, a Gly substitution in neighboring residues in b1
or b2 does not affect dimer formation caused by substitutions
in Gly10.
Dimerization via a Single Mutation Is Unique to Ub
Structure-based sequence alignments with a number of ubiqui-
tin-like proteins (Ubls) revealed that several contained Gly resi-
dues in positions corresponding to Gly10 in Ub. We introduced
Val substitutions at these positions in two Ubls derived from
NEDD8 and SUMO2, and investigated their oligomeric state by
size-exclusion chromatography (Figure 3D). No dimer formation
was apparent in either Val-substituted Ubl although there was a
marked reduction in solubility of the NEDD8-Ubl variant.
Because the SUMO2-Ubl contains a second Gly in the loop be-
tween b1 and b2 that might potentially compensate for any
inflexibility introduced as observed in Ub, we also analyzed the
SUMO2-Ubl G24A G27V double mutant using gel-filtration chro-
matography and found no evidence of oligomerization (Fig-
ure 3D). These data suggest that other surrounding residues
contribute to the stability of Ubl folds, and that further mapping
of these regions is required to ascertain how these residues
contribute to dimer formation and stability.
DISCUSSION
Ub scaffold libraries have been used to develop affinity reagents
for a broad range of applications including probing cell signaling
networks, elucidating protein function, and delivering targeted(C) Normalized analytical size-exclusion chromatogram of Ub74 G10V and Ub74
individually replaced with Gly. See also Figures S1E and S1F.
(D) Normalized analytical size-exclusion chromatogram of NEDD8-Ubl, NEDD8-U
dimer formation in any of these Ubl variants.
(E) As in (A) but including the K48-linked diUb from PDB: 5MN9, colored gray.
6 Structure 27, 1–8, September 3, 2019biotherapeutics (Brown et al., 2016; Gabrielsen et al., 2017; Gor-
elik et al., 2016; Job et al., 2015; Lorey et al., 2014; Manczyk
et al., 2017; Zhang et al., 2016, 2017a, 2017b). Generating new
search spaces relies on increasing the diversity of the Ub scaf-
fold libraries. In a previous study, we serendipitously identified
UbV.XR, which self-associates to form a stable non-covalent
dimer and only binds its target as a dimer. In UbV.XR, Ala10 in
the b1b2 loop is essential for dimerization but whether there
are contributions from other mutations in this region is unknown.
To facilitate the use of this non-covalent dimer conformation as a
scaffold to generate additional UbV libraries, we investigated
substitution requirements in the b1b2 loop of Ub to convert it
to a dimer. We found that a single substitution of Gly10 with
Ala or Val is sufficient to induce dimerization of Ub and that
Ub74 G10V reverts to a monomeric state when certain other res-
idues from the b1b2 loop are substituted with Gly. A crystal
structure of Ub74 G10V shows that the dimer interface resem-
bles that of UbV.XR, and SAXS analyses suggest this dimer
conformation is also present in solution. Substitution of Gly to
Val in the b1b2 loop of NEDD8-Ubl or SUMO2-Ubl does not pro-
mote dimerization, demonstrating that this mechanism for dimer
formation is specific to Ub.
Of the Gly10 substitutions tested (Ala, Val, Leu, Met, Phe, or
Arg), only Val and Ala promoted dimer formation. Interestingly,
the monomeric populations of each of these variants had lower
melting point temperatures than either wild-type Ub or the other
UbVs. This mutation-induced instability might be a factor that al-
lows b1 to detach from the b sheet in the globular body of the
monomer to form the dimer. Once formed, the dimer appears
to be very stable, as there was no evidence of dissociation to a
monomer. However, Ub74 G10V reverted to monomer when
other residues in the b1b2 loop were substituted with glycine,
suggesting that the presence of a Gly in this loop plays a critical
role in Ub’s ability to form a non-covalent domain-swapped
dimer. Nevertheless, our data show that this non-covalent
dimerization is only observed in Ub and not other Ubls despite
their high structural conservation; hence, it is likely that other fac-
tors also play a role in dimerization.
What drives dimer formation is as yet unclear. Despite ubiqui-
tin being a compact globular protein, it has several flexible re-
gions including the C-terminal tail that is essential for conjugation
and the b1b2 loop (Gladkova et al., 2017). We hypothesize that
two steps occur in the formation of Ub74 G10A or G10V dimers:
these Gly10 mutations promote instability, allowing b1 to detach
from b2, and, while the strand is dislodged, it interacts with a
similarly b1-detached neighboring molecule to form a dimer.
Another dimeric UbV selective for the deubiquitinase USP15 ex-
hibits the same strand exchange as observed in Ub74 G10V
(Teyra et al., 2019); although there is no substitution of Gly10, a
loop insertion is present between residues Leu8 and Thr9 that
may account for the required destabilization. Whether there are
other factors that contribute to dimer formation or whether there
is a threshold for stability is unclear. The melting temperature ofcompared with variants in which other residues in the b1b2 loop have been
bl G10V, SUMO2-Ubl, and SUMO2-Ubl G24A G27V. There is no evidence of
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than that of Ub74, and in cases such as this, two free b1-strand
molecules may not encounter one another so it is energetically
more favorable to return to a native state.
There are a number of diUb structures available in the PDB that
are formed from linkages involving Lys side chains or linear Met1
chains. The overall shape of the Ub74 G10V dimer and the
various diUbs appear similar when superposed, as they
comprise two globular proteins connected by a short linker con-
sisting of the C-terminal tail and a lysine side chain, or by the
elongated b1 observed in Ub74 G10V. However, superposition
of one Ub chain from each structure reveals that the two Ub
chains relate to each other through a wide range of angles.
The closest structural arrangement to Ub74 G10V is the open
conformation of K48-linked diUb from 5MN9 in which the diUb
is part of a complex with a fragment of the DUB MINDY-1/
FAM63A. In both Ub74 G10V and this K48-linked diUb, the dis-
tance between Leu69 and Leu690 is 22 A˚ (Figure 3E).
Based on rotational conformational differences between the
two Ub bodies of dimeric subunits within the asymmetric unit,
our Ub74 G10V dimer structure suggests that the dimerization
arm is flexible. This feature was not observed in our prior UbV.XR
structure, but when UbV.XR is bound to XR it becomes more
compact and the distance between the Leu69 in each UbV.XR
decreases from 20 to 15 A˚ (Gabrielsen et al., 2017). Interactions
with XR appear to stabilize the dimerization arm in UbV.XR and
increase the dimer compactness, suggesting that the Ub dimer
may also become more compact upon binding to another
protein.
The discovery of dimeric UbV.XR and its stimulatory effect
upon its target, XIAP RING, suggests there is scope to expand
upon the diversity covered by current phage-displayed UbV li-
braries. In this study, we set out to elucidate which Ub residues
require substitution to form a dimeric scaffold and found that
substitution of Gly10 to Val or Ala was sufficient, provided no
other Gly substitutions are introduced in the b1b2 loop. These
substitutions can be used to develop next-generation libraries
that will encode dimeric UbVs with novel interfaces for protein
recognition. There is increased interest in developing dimeric
UbVs, as these may allow improved specificity and binding
and exploit bivalent avidity effects. Recently, Teyra et al. (2019)
developed linear dimeric UbVs selective for the deubiquitinase
USP15 by linking together UbVs that bind tandem domains of
this enzyme. These dimeric UbVs show an increased binding
to and inhibition of the deubiquitinase USP15 compared with
other deubiquitinases. Should a dimeric UbV library be available
for screening, we anticipate that this approach may be useful for
a number of applications, particularly for elucidating and manip-
ulating the activity of hetero- and homodimeric RING E3s.STAR+METHODS
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pGEX4T1 HG TEV Ub74 G10V K11G This paper N/A
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pGEX4T1 HG TEV Ub74 G10V I13G This paper N/A
pGEX4T1 HG TEV Ub74 G10V T14G This paper N/A
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pGEX4T1 HG TEV NEDD8 74 G10V This paper N/A
pGEX4T1 HG TEV SUMO2 91 This paper N/A
pGEX4T1 HG TEV SUMO2 91 G27V This paper N/A
pGEX4T1 HG TEV SUMO2 91 G24A G27V This paper N/A
Software and Algorithms
GraphPad Prism version 7 GraphPad Software http://www.graphpad.com; RRID: SCR_002798
xia2 pipeline (Winter, 2010) http://xia2.github.io; RRID: SCR_015746
XDS (Kabsch, 2010) http://xds.mpimf-heidelberg.mpg.de/; RRID:
SCR_015652
AIMLESS (Evans and Murshudov, 2013) http://www.ccp4.ac.uk; RRID: SCR_015747
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PHENIX (Adams et al., 2010) https://www.phenix-online.org/; RRID:
SCR_014224
COOT (Emsley et al., 2010) https://www2.mrc-lmb.cam.ac.uk/personal/
pemsley/coot/; RRID: SCR_014222
MOLPROBITY (Chen et al., 2010) http://molprobity.biochem.duke.edu/; RRID:
SCR_014226
ALINE (Bond and Sch€uttelkopf, 2009) http://bondxray.org/software/aline.html; RRID:
SCR_016886
PyMOL The PyMOL Molecular Graphics
System, v. 1.8.4.0, Schrodinger,
LLC
http://www.pymol.org; RRID: SCR_000305
SCA˚TTER SCA˚TTER Version 3.1r http://www.bioisis.net; RRID: SCR_017271
FoXS (Schneidman-Duhovny et al., 2013) https://modbase.compbio.ucsf.edu/foxs/; RRID:
SCR_017269
DAMAVER (Volkov and Svergun, 2003) https://www.embl-hamburg.de/biosaxs/damaver.
html; RRID: SCR_015648
SASRES (Tuukkanen et al., 2016) https://www.embl-hamburg.de/biosaxs/software.
html; RRID: SCR_015648
DAMFILT (Volkov and Svergun, 2003) https://www.embl-hamburg.de/biosaxs/damaver.
html; RRID: SCR_015648
GASBOR (Svergun et al., 2001) https://www.embl-hamburg.de/biosaxs/gasbor.
html; RRID: SCR_015648
Other
Glutathione agarose resin Web Scientific Cat#ABT 4B-GLU-100
Ni2+ agarose resin Web Scientifc Cat#ABT 6BCL-QHNi-100
SD75 26/60 size-exclusion chromatography
column
GE Healthcare Cat#28-9898-34
SD75 10/300 analytical size-exclusion
chromatography column
GE Healthcare Cat#17-5175-01
Protein Thermal Shift Kit Applied Biosystems, Thermo
Fisher Scientific
Cat#4461146
7500 FAST RT-PCR machine Applied Biosystems, Thermo
Fisher Scientific
N/A
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Danny
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Recombinant Proteins
Recombinant proteins were overexpressed in Escherichia coli BL21(lDE3) GOLD cells. Cultures were grown at 37C in Luria Bertani
media until an OD600 of 0.6–0.8 was reached, followed by induction with 0.2 mM isopropyl b-D-1-thiogalactopyranoside and incu-
bation at 18–20C overnight.
METHOD DETAILS
Generation of New Constructs
b1-b2 loop variants of Ub and Ubls were generated using standard PCR-ligation techniques and verified by automated sequencing.
All UbVs and Ubls were cloned into pEX4T1 (GE Healthcare) modified with a TEV cleavage site and an N-terminal His-tag
(pGEX4T1 HG TEV) and include DNA encoding the sequence GGS at the N-terminus prior to Met1 but lacking the C-terminal
diglycine.
Protein Purification
After expression, cell cultures were harvested by low-speed centrifugation, resuspended in 50mM Tris-HCl pH 7.6, 200 mM NaCl,
2.5 mM phenylmethanesulfonyl fluoride (PMSF) and 15 mg lysozyme per liter culture, before being flash frozen in liquid nitrogen.
The pellets were thawed and sonicated. Lysates were cleared by centrifugation at 50,000 g and then loaded onto glutathione agarose
resin, followed by incubation for 1-2 hours. The proteins were washed in 50 mM Tris-HCl pH 7.6, 200 mM NaCl, 5 mM b-mercaptoe-
thanol (BME), and eluted in 25 mM Tris-HCl pH 7,6, 150 mM NaCl, 5 mM BME, 10 mM glutathione. TEV protease was used to cleave
the affinity tags, which were removed by further Ni2+-affinity chromatography. The proteins were concentrated to 5 ml, and applied
onto a 26/60 SD75 gel filtration column, pre-equilibrated in 25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1 mM DTT. All purification steps
were carried out at 4C.
Analytical Gel Filtration
Ub74 and variants were applied onto a Superdex 75 10/300 column pre-equilibrated in 25 mM Tris-HCl, pH 7.6, 150 mMNaCl, 1 mM
DTT at constant flow-rate at 4C.
Differential Scanning Fluorimetry (DSF) Assays
Proteins were mixed with buffer and ROX dye using the Protein Thermal Shift Dye Kit and thermal scanning (25 to 95C at 1C per
minute) was performed using an Applied Biosystems 7500 FAST RT-PCR machine. Assay reactions were set up in triplicate in a
96-well PCR plate. Curve fitting and melting temperature calculations were performed using the basic Boltzmann sigmoid function
in GraphPad Prism (version 7).
Small-Angle X-Ray Scattering (SAXS) Data Collection and Analyses
Protein was brought to Diamond Light Source station B21 for bioSAXS. Data were collected on a range of protein concentrations for
both Ub74 G10V (from 50 mg/ml to 3.1 mg/ml) and Ub74 (from 25 mg/ml to 3.1 mg/ml). The protein samples were kept chilled until
injected into the x-ray beam. Data were processed and the distance distribution function and maximum distance (Dmax) were calcu-
lated using SCA˚TTER version 3.1r (http://www.bioisis.net).
Theoretical scattering curves were calculated and fitted against available crystal structures using FoXS (Schneidman-Duhovny et
al., 2013). Twenty ab initiomodels were calculated by GASBOR (Svergun et al., 2001) and average models of these were calculated
using DAMAVER and DAMFILT (Volkov and Svergun, 2003). The resolution of the space-filled models was calculated using SASRES
(Tuukkanen et al., 2016).
Crystallization
Ub74G10Vwas concentrated to approximately 50mg/ml, andmixed in a 1:1 ratio of reservoir. Long rods, appearing within 24 hours,
were grown using sitting drop vapour diffusion in 96 well trays. Initial crystals hits occurred in Morpheus HT-96 screen, condition 1.
Final crystals were grown using hanging drop vapour diffusion in 24 well trays, where protein wasmixed with the reservoir at 2:1 ratio.
Furthermore, Buffer System 1 from the original condition was substituted with 1M MES pH 6.5.
Structure Determination and Refinement
Crystals were frozen without additional cryo-protection and brought to Diamond Light Source station I04-1. Data were collected in
0.2 slices, and processed by the XIA2 pipeline, relying on XDS (Kabsch, 2010) and AIMLESS (Evans and Murshudov, 2013). The
structure was determined by molecular replacement using the MoRDA server (Vagin and Lebedev, 2015), which utilized a library
of structures of ubiquitin from the PDB, finally determining the structure using chain B from PDB ID 3ZNZ. Refinement was done
in PHENIX (Adams et al., 2010), with inspection of the maps and manipulation of the model in COOT (Emsley et al., 2010). Waters
were added in COOT. Polder density maps were calculated in PHENIX and used to confirm the model.Structure 27, 1–8.e1–e4, September 3, 2019 e3
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mation, Structure (2019), https://doi.org/10.1016/j.str.2019.06.008QUANTIFICATION AND STATISTICAL ANALYSIS
Table 1 and Figure 2 contain quantitative parameters related to data and refinement statistics for X-ray crystallography and
SAXS experiments. Melting temperatures related to Figure 1E were obtained from the inflection point of melting curves measured
in triplicate and fitted with the basic Boltzmann sigmoid function in GraphPad Prism (version 7). Normalization of absorbance on
gel filtration chromatograms (Figures 1, 3, and S1) was performed using the following equation:
Anorm =
ðA AminÞ
ðAmax  AminÞ
DATA AND CODE AVAILABILITY
The accession number for atomic coordinates and structure factors for the X-ray crystal structures of Ub74 G10V is PDB: 6QK9.
SAXS data are available in the Mendeley Data Repository (https://doi.org/10.17632/wbbjg5kwr8.1). Other data generated in this
study are available from the Lead Contact upon request.e4 Structure 27, 1–8.e1–e4, September 3, 2019
